Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02676375Phase 4Completed

Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment

Role: lead

NCT01526005Completed

Brain Nicotine Receptor Density & Response to Nicotine Patch

Role: lead

NCT00287599Completed

Rapid Identification of Key Pathogens in Wound Infection by Molecular Means

Role: lead

All 3 trials loaded